The Capital Most Founders Never See
A diagnostics chain across tier-2 towns was told its margins were thin and its geography hard. In the language of a whole class of investors, it was an impact business, and there were funders whose entire job was to back exactly what it was building. Not a shortage of capital: a blind spot about which capital.
Summary
- Every capital journey has two lanes. The commercial one runs angel, seed, Series A, venture debt. The second runs from grants and catalytic capital through guarantees and concessional debt to impact equity and development finance.
- Impact finance is who the money is, and why. Blended finance is how you structure it: a slice of concessional capital de-risks a deal so commercial investors who would have said no now say yes.
- Four gates decide whether the second lane is open to you: theme, intentionality, additionality and measurability. Additionality is the one founders fail most, and the one that matters most.
A few years ago I sat with a founder who ran a diagnostics chain across tier-2 towns. Good business. Real revenue. Serving people who had never had a lab within fifty kilometres of home.
He was exhausted from raising. He had pitched a dozen venture funds, been told his margins were thin and his geography was hard, and he had started to believe the money simply wasn't there for a business like his.
Here is what he did not know. His business was, in the language of a whole class of investors, an impact business. Affordable diagnostics for an underserved population is one of the most fundable stories in the market, for the right kind of capital. There were foundations, development finance institutions and blended facilities whose entire job was to fund exactly what he was building, often on cheaper and more patient terms than the venture money he was chasing.
He was standing at a crossroads with two roads in front of him. He could only see one.
That is the problem I want to talk about. Not a shortage of capital. A blind spot about which capital, and how to reach it.
Every capital journey has two lanes
Think of a founder's fundraising life as a road that runs the length of the company. Most of us are taught only one lane on that road: angel, then seed, then , then , then private or the public markets. Commercial capital, priced on growth and returns.
There is a second lane running right alongside it, and most founders never look over. It starts with grants and CSR money. It moves through catalytic and first-loss capital, guarantees, and concessional debt priced below the market. It ends in impact equity from funds that expect a return and a measurable outcome, and in development finance from institutions that exist to serve markets commercial money leaves behind.
The two lanes are not rivals. The clever move is to run them together: to use the patient, cheaper money in the second lane to take the risk off the table so the commercial money in the first lane is willing to come in. That is the whole idea behind blended finance, and I'll come back to it.
But you cannot drive a lane you cannot see. So the first job, the one that changes everything downstream, is simply knowing whether the second lane is open to you at all.
Two words, said as if they mean the same thing
Impact finance is capital put to work with the deliberate intention of producing a measurable social or environmental outcome alongside a financial return. Some of it expects a full market return. Some of it will accept less, or wait longer, in exchange for the outcome.
Blended finance is not a type of money. It is a technique. You take a slice of concessional capital (money from a foundation, a government, a development institution that is willing to earn less or take the first loss) and you use it to de-risk a deal so that ordinary commercial investors, who would have said no on their own, now say yes. The concessional slice is the lever. The commercial money it pulls in is the prize.
There is a number that measures how well this works: the mobilisation ratio, how many rupees of private money each rupee of concessional money brings in. India's flagship health facility reports pulling in roughly eight to ten rupees of commercial and debt capital for every rupee of philanthropy it puts down. That is the magic of the second lane done well.
So: impact finance is who the money is, and why. Blended finance is how you structure it. A founder can raise impact capital with no blending at all. A blended deal almost always sits inside an impact story.
The real gate: are you even an impact company?
Here is where most founders get it wrong, in both directions.
Some assume that because they do something good, they qualify. Others assume that because they run a normal commercial business, they don't. Both are guessing, because neither knows the test the money actually applies.
An investor does not fund "good intentions." They fund a business that passes four gates.
One: theme. Does the business sit on a problem the world has agreed matters: health access, financial inclusion, climate, food and farming, education, clean water, women's livelihoods? A lender to people the banks ignore passes. A diagnostics chain in small towns passes. Their founders rarely realise it.
Two: intentionality. Is the impact built into how the business makes money, or is it a side effect? The money can tell the difference between a company that reaches the underserved because that is the strategy and one that happens to.
Three: additionality. This is the gate founders fail most, and the one that matters most. Is there a genuine gap that patient or concessional capital is justified in filling, because commercial money, left alone, would not have served this segment? If ordinary capital already flows here freely, no foundation will subsidise it. Additionality is the entire moral and economic case for the second lane. No additionality, no concessional money.
Four: measurability. Can you actually track and prove the outcome, over time, with data? An impact claim with nothing underneath it is not a weak claim. It is a disqualifying one. The money reads it as impact-washing and walks away.
I keep on my wall a line from W. Edwards Deming: in God we trust; all others must bring data. Nowhere is that truer than here.
In this lane, the story is not the pitch. The evidence is the pitch.
The same business, seen through different eyes
Say you pass the four gates. You are not done, because the different pools of money in the second lane do not measure impact the same way. They share a grammar, but they speak different dialects, and a founder who can't switch between them stays invisible.
The shared grammar is worth learning once. It runs like this: a theory of change (the honest cause-and-effect chain from what you do to the outcome you claim), described across five dimensions the whole industry agreed on (what the outcome is, who experiences it, how much of it there is, your genuine contribution to it, and the risk it doesn't happen), then measured with a standard set of metrics and mapped to the global goals everyone recognises.
Now the dialects:
A foundation wants your theory of change and your additionality. It is asking, "does our money unlock something that wouldn't have happened otherwise?"
A development finance institution wants harmonised, comparable numbers (jobs, reach, emissions, the gender lens) and it wants rigorous environmental and social safeguards. It is asking, "development outcomes, at scale, done safely."
An impact fund wants both barrels at once: a real financial return and disciplined, often independently-verified impact. It is asking, "profit with purpose, and can you prove the purpose?"
An outcome funder will pay you only when an independent party confirms the result actually happened.
And in India, the Social Stock Exchange wants a certified social and a published annual impact report before it lets you raise a rupee.
Same business. Five different conversations. The work, the real work, is translation: taking one honest set of facts about your company and telling it correctly to each kind of money. That is not spin. Spin is what happens when there's no data. Translation is what happens when there is.
The stack, from cheapest to most commercial
When the lane is open and the story is straight, the becomes concrete. Capital stacks in layers, and you climb from the most patient at the bottom to the most commercial at the top:
Grants and philanthropy, which cost you nothing but reporting. Catalytic and first-loss capital, which absorbs the early risk so others will follow. Guarantees, which cost a fee and unlock lenders. Concessional debt, priced below the market. Technical-assistance grants that ride alongside an investment to build your capacity. Then commercial impact equity, dilutive and expecting a real return. Then senior debt from development institutions and banks. And, for the right programme, outcome-based funding paid on verified results.
The art is sequencing. Put the concessional layer in first, in the right place, and it does the heavy lifting of de-risking everything above it. Done well, a small slice of patient money changes the price and the availability of all the capital that sits on top of it.
The part nobody warns you about
Founders treat impact measurement as a hurdle at the door, something to get past to close the round. It isn't. It is a discipline that never ends.
Every serious funder in the second lane requires ongoing, often independently-verified impact reporting for as long as they're invested. Development institutions want their harmonised numbers, year after year. Impact funds that follow the market discipline must disclose and get verified annually. The Social Stock Exchange requires an annual impact report and a social audit. Foundations want to see the outcomes their grant was supposed to buy.
Most founders are not set up to do this, and it quietly becomes a burden. But turned around, it is an asset: a credible, repeatable evidence system that makes the next raise easier and the next funder faster to yes. The companies that treat measurement as infrastructure, not paperwork, raise better for years.
The roadmap tells you where the money is; positioning is how you win it
I think about this work in a simple way now.
The capital roadmap answers where: which lanes are open to you, which instruments, in what order, from which funders. That's the map.
Positioning answers how: how you show up, in the right dialect, with the evidence in hand, so the money says yes. That's the driving.
The founder with the diagnostics chain had a great map all along and never knew it. Once we drew it, once he saw the second lane, understood which gates he passed, and learned to tell his story to the kind of money built to fund him, the raise stopped feeling like pushing a boulder uphill. He wasn't a worse commercial bet than the funds had told him. He was a different bet, and he'd been pitching the wrong room.
If you are building something that serves people the market usually skips, there is a real chance the second lane is open to you right now, and you cannot see it. That is worth ten minutes to find out.
If you want to know whether your business qualifies for the impact and blended finance lane, and which instruments and funders fit your stage, start with the Capital Roadmap Diagnostic. It runs the four gates and shows you which lanes are open.
How useful was this article?
One tap. It tells us what to write more of.
The next one
Get what we publish next, by email.
Working notes on raising, borrowing, protecting, growing and structuring capital in India. One email a week at most, and you can leave any time.
We use your address only to send this. See our privacy policy.
We store your address to send you these emails and nothing else. See our privacy policy.
Related reading
